– Evaluating a Next Generation Anti-CD40L Antibody as a Therapy for Patients with ALS

Time: 12:00 pm
day: Day Two AM

Details:

  • The rationale for targeting CD40L in patients with ALS
  • Results of a pilot study targeting CD40L in patients with ALS
  • Looking to the future with targeting CD40L in patients with ALS

Speakers: